|
|
Volumn 3, Issue , 1998, Pages 271-278
|
|
Farnesyltransferase inhibitors: A cell signalling approach to the design of efficacious anticancer agents
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER;
4 (8 CHLORO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE) 1 (4 PYRIDYLACETYL)PIPERIDINE;
ANTINEOPLASTIC AGENT;
B 581;
BENZODIAZEPINE;
BMS 186511;
COMPOUND 75;
FARNESYL TRANS TRANSFERASE;
FTI 265;
L 731734;
N (8 AMINO 2 BENZYL 5 ISOPROPYL 9 MERCAPTO 3,6 NONADIENOYL)METHIONINE;
N (8 AMINO 2 BENZYL 5 ISOPROPYL 9 MERCAPTO 3,6 NONADIENOYL)METHIONINE METHYL ESTER;
N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER;
N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE;
N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER;
PD 169451;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
COLON CANCER;
DRUG DESIGN;
ENZYME INHIBITION;
HUMAN;
JURISPRUDENCE;
ONCOGENE RAS;
PANCREAS CANCER;
REVIEW;
|
|
EID: 0031957698
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.3.1.271 Document Type: Review |
|
Times cited : (3)
|
|
References (29)
|
